(Q39214055)

10 September 2017

title

Long-term toxicity of bevacizumab therapy in neurofibromatosis 2 patients (English)

1 reference

neurofibromatosis type II

10 September 2017

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Katherine M Slusarz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Alona Muzikansky

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Sanjeev A Francis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Scott R Plotkin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

8 April 2014

1 reference

Cancer Chemotherapy and Pharmacology

10 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1197-1204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

cites work

Neurofibromatosis type 2

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Hearing improvement after bevacizumab in patients with neurofibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Increased risk of high-grade hypertension with bevacizumab in cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

Evaluation of clinical diagnostic criteria for neurofibromatosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-014-2456-2

10.1007/S00280-014-2456-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json

release_edmedxabcjcxhihc6rfurosfku

13 June 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24710627%20AND%20SRC:MED&resulttype=core&format=json